Evidence map›Paper›PMID 9566877›Full record

ArticleMolecular and cellular biology1998

Multiple Grb2-mediated integrin-stimulated signaling pathways to ERK2/mitogen-activated protein kinase: summation of both c-Src- and focal adhesion kinase-initiated tyrosine phosphorylation events.

D D Schlaepfer, K C Jones, T Hunter

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 138 papers.

0numbers the graph read from it
0cells of the map it votes in
138citing papers in PubMed
13.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

138 citing papers in PubMed, 396 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. New insights into RAS in head and neck cancer.Biochimica et biophysica acta. Reviews on cancer · 2023
    Review
  6. An impaired splicing program underlies differentiation defects in hSOD1Cellular and molecular life sciences : CMLS · 2023
    Article
  7. Article
  8. Article
  9. ERK signaling for cell migration and invasion.Frontiers in molecular biosciences · 2022
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Gain-of-function hot spot mutant p53Translational oncology · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Vemurafenib Inhibits Active PTK6 inMolecular cancer therapeutics · 2019
    Article

78 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

D D SchlaepferDepartment of Immunology, The Scripps Research Institute, La Jolla, California 92037, USA. dschlaep@scripps.edu
K C Jones
T Hunter
Scripps Research Institute · US

Funding

Viral Vector Core (VVC)P30CA014195 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI Ye Zheng · 1985 to 2026
$82.8M
TYROSINE PHOSPHORYLATION AND INTEGRIN SIGNALINGR29CA075240 · NCI · SCRIPPS RESEARCH INSTITUTE · PI SCHLAEPFER, DAVID D · 1997 to 2001
$259k
ROLE OF PROTEIN PHOSPHORYLATION IN GROWTH CONTROLR35CA039780 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI HUNTER, TONY R. · 1985 to 1998
–
NCI NIH HHS CA14195NCI NIH HHS CA39780NCI NIH HHS P30 CA014195NCI NIH HHS R29 CA075240NCI NIH HHS R29 CA75240
6 · The paper itself

Abstract

Fibronectin receptor integrin-mediated cell adhesion triggers intracellular signaling events such as the activation of the Ras/mitogen-activated protein (MAP) kinase cascade. In this study, we show that the nonreceptor protein-tyrosine kinases (PTKs) c-Src and focal adhesion kinase (FAK) can be independently activated after fibronectin (FN) stimulation and that their combined activity promotes signaling to extracellular signal-regulated kinase 2 (ERK2)/MAP kinase through multiple pathways upstream of Ras. FN stimulation of NIH 3T3 fibroblasts promotes c-Src and FAK association in the Triton-insoluble cell fraction, and the time course of FN-stimulated ERK2 activation paralleled that of Grb2 binding to FAK at Tyr-925 and Grb2 binding to Shc. Cytochalasin D treatment of fibroblasts inhibited FN-induced FAK in vitro kinase activity and signaling to ERK2, but it only partially inhibited c-Src activation. Treatment of fibroblasts with protein kinase C inhibitors or with the PTK inhibitor herbimycin A or PP1 resulted in reduced Src PTK activity, no Grb2 binding to FAK, and lowered levels of ERK2 activation. FN-stimulated FAK PTK activity was not significantly affected by herbimycin A treatment and, under these conditions, FAK autophosphorylation promoted Shc binding to FAK. In vitro, FAK directly phosphorylated Shc Tyr-317 to promote Grb2 binding, and in vivo Grb2 binding to Shc was observed in herbimycin A-treated fibroblasts after FN stimulation. Interestingly, c-Src in vitro phosphorylation of Shc promoted Grb2 binding to both wild-type and Phe-317 Shc. In vivo, Phe-317 Shc was tyrosine phosphorylated after FN stimulation of human 293T cells and its expression did not inhibit signaling to ERK2. Surprisingly, expression of Phe-925 FAK with Phe-317 Shc also did not block signaling to ERK2, whereas FN-stimulated signaling to ERK2 was inhibited by coexpression of an SH3 domain-inactivated mutant of Grb2. Our studies show that FN receptor integrin signaling upstream of Ras and ERK2 does not follow a linear pathway but that, instead, multiple Grb2-mediated interactions with Shc, FAK, and perhaps other yet-to-be-determined phosphorylated targets represent parallel signaling pathways that cooperate to promote maximal ERK2 activation.

Indexed as

Adaptor Proteins, Signal TransducingAdaptor Proteins, Vesicular Transport3T3 CellsAnimalsCalcium-Calmodulin-Dependent Protein KinasesCell Adhesion MoleculesCell MovementCrk-Associated Substrate ProteinCytoskeletal ProteinsFibronectinsFocal Adhesion Kinase 1Focal Adhesion Protein-Tyrosine KinasesGene Expression RegulationGRB2 Adaptor ProteinIntegrinsMiceAdaptor Proteins, Signal TransducingAdaptor Proteins, Vesicular TransportBcar1 protein, mouseCalcium-Calmodulin-Dependent Protein KinasesCell Adhesion MoleculesCrk-Associated Substrate ProteinCytoskeletal ProteinsFibronectinsFocal Adhesion Kinase 1Focal Adhesion Protein-Tyrosine KinasesGRB2 Adaptor ProteinGrb2 protein, mouseIntegrinsMitogen-Activated Protein Kinase 1PaxillinPhosphoproteinsProtein Kinase CProteinsProtein-Tyrosine KinasesProto-Oncogene Proteins pp60(c-src)Ptk2 protein, mousePxn protein, mouseReceptors, FibronectinRetinoblastoma-Like Protein p130SHC1 protein, humanShc1 protein, mouseShc Signaling Adaptor ProteinsSrc Homology 2 Domain-Containing, Transforming Protein 1Tyrosine

Identifiers

PMID9566877
PMCPMC110637
OpenAlexW2161873278

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.